Article

Pharmaceutical Antitrust Issues in Canada: An Update, Antitrust Health Care Chronicle

Author: Anita Banicevic

Recent actions and statements from the Competition Bureau confirm that it has set its sights on the pharmaceutical industry and is preparing for increased intervention and enforcement in this sector.

Download this article.

Key Contacts

Related

Small Mergers Loom Large on Canadian Competition Bureau’s Radar

Sept. 30, 2019 - Canada’s Competition Bureau is actively seeking and reviewing smaller acquisitions that may not exceed pre-merger notification thresholds under the Competition Act but that may nonetheless raise substantive competition issues. The Bureau’s demonstrated interest in evaluating smaller mergers...

Top Court Expands Scope of Potential Liability in Price-Fixing Class Actions

Sept. 24, 2019 - The Supreme Court of Canada has released its long-awaited decision in two companion appeals that have significant implications for class actions alleging conduct that contravenes the criminal provisions found in Part VI of the Competition Act (Act). In its decision in Pioneer Corporation...